Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
MT-2 is one of the very few substances that cross into the central nervous system in sufficient quantities to have an effect on TRH expression
Parents agreed to needful investigations and genetic testing at birth
Your health and weight and what it's like to be free
While Phase II trials in heart failure and primary mitochondrial myopathy did not meet primary efficacy endpoints, the TAZPOWER trial in Barth syndrome demonstrated significant improvements in muscle strength and sixminute walk distance, leading to FDA accelerated approval in 2025 [3] [10]
"They're certainly not endorsed by us," Syron said Thursday
US$ 21.66
US$ 24.82
US$ 28.81
US$ 29.49
